These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34491776)

  • 1. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34491776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34315231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
    Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
    J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.
    Schramm R; Zittermann A; Morshuis M; Schoenbrodt M; von Roessing E; von Dossow V; Koster A; Fox H; Hakim-Meibodi K; Gummert JF
    ESC Heart Fail; 2020 Jun; 7(3):908-914. PubMed ID: 32190985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
    Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
    J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support.
    Numan L; Ramjankhan FZ; Oberski DL; Oerlemans MIFJ; Aarts E; Gianoli M; Van Der Heijden JJ; De Jonge N; Van Der Kaaij NP; Meuwese CL; Mokhles MM; Oppelaar AM; De Waal EEC; Asselbergs FW; Van Laake LW
    ESC Heart Fail; 2021 Apr; 8(2):1596-1603. PubMed ID: 33635573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widening care gap in VAD therapy.
    Conway J; Amdani S; Morales DLS; Lorts A; Rosenthal DN; Jacobs JP; Rossano J; Koehl D; Kirklin JK; Auerbach SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1710-1724. PubMed ID: 37591455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: the EUROMACS analysis.
    Potapov EV; Nersesian G; Lewin D; Özbaran M; de By TMMH; Stein J; Pya Y; Gummert J; Ramjankhan F; Zembala MO; Damman K; Carrel T; Meyns B; Zimpfer D; Netuka I
    Eur J Cardiothorac Surg; 2021 Sep; 60(3):579-587. PubMed ID: 33871594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis.
    Kirklin JK; Naftel DC; Myers SL; Pagani FD; Colombo PC
    J Heart Lung Transplant; 2020 Aug; 39(8):782-794. PubMed ID: 32376278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
    Inamullah O; Chiang YP; Bishawi M; Weiss M; Lutz MW; Blue LJ; Feng W; Milano CA; Luedke M; Husseini NE
    Sci Rep; 2021 Jan; 11(1):1645. PubMed ID: 33462301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry.
    Francica A; Loforte A; Attisani M; Maiani M; Iacovoni A; Nisi T; Comisso M; Terzi A; De Bonis M; Vendramin I; Boffini M; Musumeci F; Luciani GB; Rinaldi M; Pacini D; Onorati F
    Transpl Int; 2023; 36():11675. PubMed ID: 37727385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
    Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
    Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.